These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11320498)

  • 1. Adsorption of natriuretic factors in uremia.
    Franz M; Woloszczuk W; Hörl WH
    Semin Nephrol; 2001 May; 21(3):298-302. PubMed ID: 11320498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
    Takagi T; Nishikawa M; Inada M
    Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
    Clerico A; Caprioli R; Del Ry S; Giannessi D
    J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP; Feifel K; Mayer-Wehrstein R
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].
    Eisenhauer T; Talartschik J; Quentin E; Kreutzfeldt W; Scheler F
    Klin Wochenschr; 1988 Sep; 66(18):940-5. PubMed ID: 2846948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2001 May; 59(5):1928-34. PubMed ID: 11318965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
    Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
    JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
    Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
    Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in plasma immunoreactive N-terminus, C-terminus, and 4,000-dalton midportion of atrial natriuretic factor prohormone with hemodialysis.
    Winters CJ; Vesely DL
    Nephron; 1991; 58(1):17-22. PubMed ID: 1830373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form.
    Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
    Clin Chim Acta; 1990 Oct; 191(1-2):1-14. PubMed ID: 2150013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation.
    Cillo U; Bassanello M; Lancerin F; Senzolo M; Burra P; Brolese A; Zanus G; Gatti R; Cappellin E; Russo F; Favia G; D'Amico D; De Palo EF
    Clin Chim Acta; 2001 Aug; 310(1):39-48. PubMed ID: 11485753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN; Vaziri ND; Pandian MR; Kaupke J
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    ASAIO J; 1992; 38(3):M197-200. PubMed ID: 1281014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies.
    Codognotto M; Piccoli A; Zaninotto M; Mion M; Plebani M; Vertolli U; Tona F; Ruzza L; Barchita A; Boffa GM
    Clin Chem; 2007 Dec; 53(12):2097-104. PubMed ID: 17934072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
    Rascher W; Bald M; Kröner F; Tulassay T; Müller-Wiefel DE
    Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
    van der Vekens N; Decloedt A; de Clercq D; Ven S; Sys S; van Loon G
    Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.